skip to main content

CKD pre-pregnancy counselling — ESENeph MCQ

Instant feedback + full explanation. One question, done properly.

ModeratePregnancy and Kidney DiseaseCKD pre-pregnancy counsellingESENeph

A 32-year-old woman with CKD G2 A3 from IgA nephropathy is planning pregnancy. She takes ramipril and has blood pressure 126/76 mmHg; eGFR is 72 mL/min/1.73 m². She asks what medication change is needed before conception. What is the most appropriate management?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: AStop ramipril before conception

ACE inhibitors are avoided in pregnancy and should be stopped before conception or as soon as pregnancy is recognised, with alternatives such as labetalol or nifedipine used when needed. Spironolactone and mycophenolate are not appropriate pre-pregnancy substitutions. CKD increases pregnancy risk and warrants pre-pregnancy counselling. The pearl is that proteinuric CKD requires coordinated renal-obstetric care even when baseline eGFR is preserved. The competing options do not fit the renal phenotype, temporal relationship, treatment threshold or safety constraint described. Management still requires confirmation of current medicines, renal trajectory and relevant contraindications, followed by timely biochemical and clinical reassessment. Escalate urgently if life-threatening electrolyte disturbance, respiratory compromise, shock, neurological deterioration or a dialysis indication develops.

Reference: UKKA Clinical Practice Guideline on Pregnancy and Renal Disease; BNF: https://ukkidney.org/health-professionals/guidelines/clinical-practice-guideline-pregnancy-and-renal-disease